H5N1 Avian Influenza: Preventive and Therapeutic Strategies Against a Pandemic
Published 2010 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
H5N1 Avian Influenza: Preventive and Therapeutic Strategies Against a Pandemic
Authors
Keywords
-
Journal
Annual Review of Medicine
Volume 61, Issue 1, Pages 187-198
Publisher
Annual Reviews
Online
2010-01-09
DOI
10.1146/annurev.med.050908.132031
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Clinical Features of Human Influenza A (H5N1) Infection in Vietnam: 2004–2006
- (2009) Nguyen Thanh Liem et al. CLINICAL INFECTIOUS DISEASES
- Infections With Oseltamivir-Resistant Influenza A(H1N1) Virus in the United States
- (2009) Nila J. Dharan JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Triple-Reassortant Swine Influenza A (H1) in Humans in the United States, 2005–2009
- (2009) Vivek Shinde et al. NEW ENGLAND JOURNAL OF MEDICINE
- Emergence of a Novel Swine-Origin Influenza A (H1N1) Virus in Humans
- (2009) NEW ENGLAND JOURNAL OF MEDICINE
- MF59®-Adjuvanted H5N1 Vaccine Induces Immunologic Memory and Heterotypic Antibody Responses in Non-Elderly and Elderly Adults
- (2009) Angelika Banzhoff et al. PLoS One
- Full Factorial Analysis of Mammalian and Avian Influenza Polymerase Subunits Suggests a Role of an Efficient Polymerase for Virus Adaptation
- (2009) Olive T. W. Li et al. PLoS One
- Fast rise of broadly cross-reactive antibodies after boosting long-lived human memory B cells primed by an MF59 adjuvanted prepandemic vaccine
- (2009) G. Galli et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Adjuvanted H5N1 vaccine induces early CD4+ T cell response that predicts long-term persistence of protective antibody levels
- (2009) G. Galli et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Antigenic and Genetic Characteristics of Swine-Origin 2009 A(H1N1) Influenza Viruses Circulating in Humans
- (2009) R. J. Garten et al. SCIENCE
- Surveillance for Neuraminidase Inhibitor Resistance among Human Influenza A and B Viruses Circulating Worldwide from 2004 to 2008
- (2008) T. G. Sheu et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- An Adjuvanted, Low‐Dose, Pandemic Influenza A (H5N1) Vaccine Candidate Is Safe, Immunogenic, and Induces Cross‐Reactive Immune Responses in Healthy Adults
- (2008) Karin Levie et al. JOURNAL OF INFECTIOUS DISEASES
- Immune Responses of Healthy Subjects to a Single Dose of Intramuscular Inactivated Influenza A/Vietnam/1203/2004 (H5N1) Vaccine after Priming with an Antigenic Variant
- (2008) Nega Ali Goji et al. JOURNAL OF INFECTIOUS DISEASES
- Recent Avian H5N1 Viruses Exhibit Increased Propensity for Acquiring Human Receptor Specificity
- (2008) James Stevens et al. JOURNAL OF MOLECULAR BIOLOGY
- Probable limited person-to-person transmission of highly pathogenic avian influenza A (H5N1) virus in China
- (2008) Hua Wang et al. LANCET
- Rapid cloning of high-affinity human monoclonal antibodies against influenza virus
- (2008) Jens Wrammert et al. NATURE
- Glycan topology determines human adaptation of avian H5N1 virus hemagglutinin
- (2008) Aarthi Chandrasekaran et al. NATURE BIOTECHNOLOGY
- Antigenically Distinct MF59-Adjuvanted Vaccine to Boost Immunity to H5N1
- (2008) Iain Stephenson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Update on Avian Influenza A (H5N1) Virus Infection in Humans
- (2008) NEW ENGLAND JOURNAL OF MEDICINE
- A Clinical Trial of a Whole-Virus H5N1 Vaccine Derived from Cell Culture
- (2008) Hartmut J. Ehrlich et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety and Immunogenicity of a Prepandemic Influenza A (H5N1) Vaccine in Children
- (2008) Zoltan Vajo et al. PEDIATRIC INFECTIOUS DISEASE JOURNAL
- Broad Clade 2 Cross-Reactive Immunity Induced by an Adjuvanted Clade 1 rH5N1 Pandemic Influenza Vaccine
- (2008) Isabel Leroux-Roels et al. PLoS One
- Influence of Prior Influenza Vaccination on Antibody and B-Cell Responses
- (2008) Sanae Sasaki et al. PLoS One
- Safety, Humoral and Cell Mediated Immune Responses to Two Formulations of an Inactivated, Split-Virion Influenza A/H5N1 Vaccine in Children
- (2008) Tawee Chotpitayasunondh et al. PLoS One
- Evolution of Highly Pathogenic H5N1 Avian Influenza Viruses in Vietnam between 2001 and 2007
- (2008) Xiu-Feng Wan et al. PLoS One
- Combinatorial antibody libraries from survivors of the Turkish H5N1 avian influenza outbreak reveal virus neutralization strategies
- (2008) A. K. Kashyap et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Phase I and II randomised trials of the safety and immunogenicity of a prototype adjuvanted inactivated split-virus influenza A (H5N1) vaccine in healthy adults
- (2008) Terry M. Nolan et al. VACCINE
- FDA/NIH/WHO public workshop on immune correlates of protection against influenza A viruses in support of pandemic vaccine development, Bethesda, Maryland, US, December 10–11, 2007
- (2008) Maryna Eichelberger et al. VACCINE
- Safety and reactogenicity profile of an adjuvanted H5N1 pandemic candidate vaccine in adults within a phase III safety trial
- (2008) Hans C. Rümke et al. VACCINE
- Safety and immunogenicity of a prototype adjuvanted inactivated split-virus influenza A (H5N1) vaccine in infants and children
- (2008) Terry Nolan et al. VACCINE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now